| 报告期 | 净资产收益率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2026-03-31 | 5.16% | -3.01% | -65.09% | 7/68 | 2.31% | 羚锐制药 | 6.99% | 行业排名> |
| 2025-12-31 | 14.78% | 17.68% | -5.92% | 6/68 | 2.77% | 羚锐制药 | 22.39% | 行业排名> |
| 2025-09-30 | 15.71% | 5.15% | 87.69% | 6/68 | 4.88% | 达仁堂 | 25.38% | 行业排名> |
| 2025-06-30 | 8.37% | 15.45% | 57.33% | 8/68 | 3.21% | 羚锐制药 | 13.67% | 行业排名> |
| 2025-03-31 | 5.32% | 13.19% | -57.64% | 7/68 | 2.25% | 天目药业 | 9.27% | 行业排名> |
| 2024-12-31 | 12.56% | 39.71% | -15.93% | 13/68 | 3.28% | 天目药业 | 22.26% | 行业排名> |
| 2024-09-30 | 14.94% | 53.7% | 106.07% | 6/68 | 5.46% | 羚锐制药 | 20.44% | 行业排名> |
| 2024-06-30 | 7.25% | 19.64% | 54.26% | 16/68 | 2.54% | 羚锐制药 | 13.25% | 行业排名> |
| 2024-03-31 | 4.7% | 4.68% | -47.72% | 12/68 | 1.97% | 片仔癀 | 7.03% | 行业排名> |
| 2023-12-31 | 8.99% | -25.52% | -7.51% | 27/68 | 2.03% | 片仔癀 | 23.1% | 行业排名> |
| 2023-09-30 | 9.72% | -50.33% | 60.4% | 20/68 | 7.62% | 太极集团 | 22.08% | 行业排名> |
| 2023-06-30 | 6.06% | 85.89% | 34.97% | 21/68 | 5.2% | 太极集团 | 17.13% | 行业排名> |
| 2023-03-31 | 4.49% | 59.22% | -62.8% | 16/68 | 3.31% | 以岭药业 | 10.43% | 行业排名> |
| 2022-12-31 | 12.07% | 124.35% | -38.32% | 21/68 | 6.79% | *ST吉药 | 72.63% | 行业排名> |
| 2022-09-30 | 19.57% | 272.76% | 500.31% | 2/68 | 5.19% | 片仔癀 | 23.54% | 行业排名> |
| 2022-06-30 | 3.26% | -3.26% | 15.6% | 38/68 | 3.33% | 片仔癀 | 19.69% | 行业排名> |
| 2022-03-31 | 2.82% | 39.6% | -47.58% | 28/68 | 2.18% | 片仔癀 | 12.75% | 行业排名> |
| 2021-12-31 | 5.38% | 28.1% | 2.48% | 43/68 | 4.51% | 片仔癀 | 6.88% | 行业排名> |
| 2021-09-30 | 5.25% | 0.57% | 55.79% | 45/68 | 7.47% | 片仔癀 | 27.39% | 行业排名> |
| 2021-06-30 | 3.37% | 8.01% | 66.83% | 45/68 | 4.6% | 片仔癀 | 23.14% | 行业排名> |
| 2021-03-31 | 2.02% | 16.76% | -51.9% | 39/68 | 2.63% | 片仔癀 | 13.23% | 行业排名> |
| 2020-12-31 | 4.2% | -8.5% | -19.54% | 44/68 | 0.07% | 长药退 | 7.37% | 行业排名> |
| 2020-09-30 | 5.22% | -19.32% | 67.31% | 41/68 | 6.89% | 以岭药业 | 7.15% | 行业排名> |
| 2020-06-30 | 3.12% | -16.13% | 80.35% | 39/68 | 3.83% | 沃华医药 | 22.84% | 行业排名> |
| 2020-03-31 | 1.73% | -22.77% | -62.31% | 37/68 | 2.18% | 沃华医药 | 19.47% | 行业排名> |
| 2019-12-31 | 4.59% | -23.63% | -29.06% | 46/68 | 6.88% | 沃华医药 | 12.7% | 行业排名> |
| 2019-09-30 | 6.47% | 7.83% | 73.92% | 38/68 | 7.39% | 济川药业 | 7.33% | 行业排名> |
| 2019-06-30 | 3.72% | -9.49% | 66.07% | 42/68 | 4.75% | 济川药业 | 27.43% | 行业排名> |
| 2019-03-31 | 2.24% | -4.68% | -62.73% | 40/68 | 2.94% | 济川药业 | 23.05% | 行业排名> |
| 2018-12-31 | 6.01% | 16.02% | 0.17% | 44/68 | 7.89% | 济川药业 | 15.79% | 行业排名> |
| 2018-09-30 | 6% | -23.18% | 45.99% | 42/68 | 8.02% | 华润三九 | 10.23% | 行业排名> |
| 2018-06-30 | 4.11% | -9.27% | 74.89% | 38/68 | 5.05% | 济川药业 | 32.79% | 行业排名> |
| 2018-03-31 | 2.35% | 23.68% | -54.63% | 36/68 | 2.78% | 济川药业 | 27.55% | 行业排名> |
| 2017-12-31 | 5.18% | -25.04% | -33.67% | 49/68 | 9.95% | 济川药业 | 17.62% | 行业排名> |
| 2017-09-30 | 7.81% | 25.36% | 72.41% | 35/68 | 8.4% | 济川药业 | 10.07% | 行业排名> |
| 2017-06-30 | 4.53% | 27.61% | 138.42% | 36/68 | 5.23% | ST葫芦娃 | 46.01% | 行业排名> |
| 2017-03-31 | 1.9% | 7.34% | -72.5% | 38/68 | 2.66% | 济川药业 | 24.2% | 行业排名> |
| 2016-12-31 | 6.91% | -26.57% | 10.91% | 47/68 | 10.19% | *ST大药 | 15.31% | 行业排名> |
| 2016-09-30 | 6.23% | -27.73% | 75.49% | 36/68 | 9.47% | 济川药业 | 14.64% | 行业排名> |
| 2016-06-30 | 3.55% | -38.69% | 100.57% | 46/68 | 5.15% | 济川药业 | 7.64% | 行业排名> |
| 2016-03-31 | 1.77% | -30.04% | -81.19% | 41/68 | 4.17% | 维康药业 | 38.23% | 行业排名> |

微信公众号
证券之星APP


